Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-09-041476
Filing Date
2009-08-10
Accepted
2009-08-10 10:36:52
Documents
1
Period of Report
2009-07-21

Document Format Files

Seq Description Document Type Size
1 v157034_ex.html 4  
1 v157034_ex.xml 4 3615
  Complete submission text file 0001144204-09-041476.txt   5451
Mailing Address 675 ROUTE 1 SUITE B 113 NORTH BRUNSWICK NJ 08902
Business Address 675 ROUTE 1 SUITE B 113 NORTH BRUNSWICK NJ 08902 732 545 1590
Advaxis, Inc. (Issuer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1937 SWEDESFORD ROAD MALVERN PA 19355
Business Address
PATTON JAMES P (Reporting) CIK: 0001306152 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28489 | Film No.: 09998114